{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:34:46Z","timestamp":1790372086255,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"GSK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42898-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:15:31Z","timestamp":1774264531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative immunohistochemistry and the use of cellular calibrators for HER2 receptor number determination"],"prefix":"10.1038","volume":"16","author":[{"given":"Kevin","family":"McKinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"2","key":"42898_CR1","first-page":"16","volume":"12","author":"SM Gamde","year":"2024","unstructured":"Gamde, S. M., Francis, L. & Adisa, J. O. Immunohistochemistry Cancer Diagnosis: Rev. Perspect., 12(2): 16. (2024).","journal-title":"Immunohistochemistry Cancer Diagnosis: Rev. Perspect."},{"issue":"5","key":"42898_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/PAI.0000000000000750","volume":"27","author":"SA Bogen","year":"2019","unstructured":"Bogen, S. A. A root cause analysis into the high error rate in clinical immunohistochemistry. Appl. Immunohistochem. Mol. Morphology. 27 (5), 329\u2013338 (2019).","journal-title":"Appl. Immunohistochem. Mol. Morphology"},{"issue":"5","key":"42898_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/01.pap.0000213041.39070.2f","volume":"13","author":"H Yaziji","year":"2006","unstructured":"Yaziji, H. & Barry, T. Diagnostic Immunohistochemistry: what can go wrong? Adv. Anat. Pathol. 13 (5), 238\u2013246 (2006).","journal-title":"Adv. Anat. Pathol."},{"key":"42898_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00428-015-1829-1","volume":"468","author":"M Vyberg","year":"2016","unstructured":"Vyberg, M. & Nielsen, S. Proficiency testing in immunohistochemistry\u2014experiences from nordic immunohistochemical quality control (NordiQC). Virchows Arch. 468, 19\u201329 (2016).","journal-title":"Virchows Arch."},{"issue":"Pt 6","key":"42898_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1258\/000456303770367199","volume":"40","author":"JO Westgard","year":"2003","unstructured":"Westgard, J. O. Internal quality control: planning and implementation strategies. Ann. Clin. Biochem. 40 (Pt 6), 593\u2013611 (2003).","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"42898_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/PAI.0000000000000069","volume":"22","author":"EE Torlakovic","year":"2014","unstructured":"Torlakovic, E. E. et al. Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel. Appl. Immunohistochem. Mol. Morphol. 22 (4), 241\u2013252 (2014).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"1","key":"42898_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAI.0000000000000163","volume":"23","author":"EE Torlakovic","year":"2015","unstructured":"Torlakovic, E. E. et al. Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee. Appl. Immunohistochem. Mol. Morphol. 23 (1), 1\u201318 (2015).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"5","key":"42898_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.5858\/arpa.2022-0031-RA","volume":"147","author":"SA Bogen","year":"2023","unstructured":"Bogen, S. A. et al. A consortium for analytic standardization in immunohistochemistry. Arch. Pathol. Lab. Med. 147 (5), 584\u2013590 (2023).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"11","key":"42898_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.5858\/arpa.2023-0048-ED","volume":"147","author":"B Magnani","year":"2023","unstructured":"Magnani, B. & Taylor, C. R. Immunohistochemistry Should Be Regulated as an Assay. Arch. Pathol. Lab. Med. 147 (11), 1229\u20131231 (2023).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"42898_CR10","unstructured":"Guideline, I. H. Bioanalytical method validation and study sample analysis M10, in ICH Harmonised Guideline: Geneva, Switzerland. (2022)."},{"key":"42898_CR11","unstructured":"Administration, U. S.D.o.H.a.H.S.F.a.D., Bioanalytical Method Validation for Biomarkers Guidance for Industry. (2025)."},{"issue":"6","key":"42898_CR12","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.5858\/arpa.2023-0483-CP","volume":"148","author":"JD Goldsmith","year":"2024","unstructured":"Goldsmith, J. D. et al. Principles of Analytic Validation of Immunohistochemical Assays: Guideline Update. Arch. Pathol. Lab. Med. 148 (6), e111\u2013e153 (2024).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"42898_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","volume":"9","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko, N. & Reifenrath, J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn. Pathol. 9, 221 (2014).","journal-title":"Diagn. Pathol."},{"issue":"1","key":"42898_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1208\/s12248-017-0159-4","volume":"20","author":"M Azadeh","year":"2017","unstructured":"Azadeh, M. et al. Calibration Curves in Quantitative Ligand Binding Assays: Recommendations and Best Practices for Preparation, Design, and Editing of Calibration Curves. Aaps j. 20 (1), 22 (2017).","journal-title":"Aaps j."},{"key":"42898_CR15","doi-asserted-by":"publisher","unstructured":"Moutafi, M. et al. Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Lab. Invest., 102,10 (2022), 1101\u20131108 (2022). https:\/\/doi.org\/10.1038\/s41374-022-00804-9","DOI":"10.1038\/s41374-022-00804-9"},{"issue":"1","key":"42898_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41374-019-0295-9","volume":"100","author":"S Martinez-Morilla","year":"2020","unstructured":"Martinez-Morilla, S. et al. Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray. Lab. Invest. 100 (1), 4\u201315 (2020).","journal-title":"Lab. Invest."},{"issue":"5","key":"42898_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1369\/0022155417694869","volume":"65","author":"K Vani","year":"2017","unstructured":"Vani, K. et al. Analytic response curves of clinical breast cancer IHC tests. J. Histochem. Cytochemistry. 65 (5), 273\u2013283 (2017).","journal-title":"J. Histochem. Cytochemistry"},{"issue":"8","key":"42898_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1369\/0022155417714208","volume":"65","author":"K Vani","year":"2017","unstructured":"Vani, K. et al. The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control. J. Histochem. Cytochemistry. 65 (8), 463\u2013477 (2017).","journal-title":"J. Histochem. Cytochemistry"},{"issue":"7","key":"42898_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5858\/arpa.2017-0330-OA","volume":"142","author":"SR Sompuram","year":"2018","unstructured":"Sompuram, S. R. et al. Quantitative Assessment of Immunohistochemistry Laboratory Performance by Measuring Analytic Response Curves and Limits of Detection. Arch. Pathol. Lab. Med. 142 (7), 851\u2013862 (2018).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"9","key":"42898_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.5858\/arpa.2023-0187-ED","volume":"147","author":"SJ Schnitt","year":"2023","unstructured":"Schnitt, S. J., Tarantino, P. & Collins, L. C. The American Society of Clinical Oncology-College of American Pathologists Guideline Update for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch. Pathol. Lab. Med. 147 (9), 991\u2013992 (2023).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"6","key":"42898_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41571-025-01016-y","volume":"22","author":"CJ Robbins","year":"2025","unstructured":"Robbins, C. J., Bates, K. M. & Rimm, D. L. HER2 testing: evolution and update for a companion diagnostic assay. Nat. Rev. Clin. Oncol. 22 (6), 408\u2013423 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"42898_CR22","doi-asserted-by":"publisher","first-page":"104233","DOI":"10.1016\/j.labinv.2025.104233","volume":"105","author":"NNN Chan","year":"2025","unstructured":"Chan, N. N. N. et al. Validation and Prospective Testing of a High-Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides. Lab. Invest. 105 (12), 104233 (2025).","journal-title":"Lab. Invest."},{"issue":"2","key":"42898_CR23","doi-asserted-by":"publisher","first-page":"104127","DOI":"10.1016\/j.esmoop.2024.104127","volume":"10","author":"S Wu","year":"2025","unstructured":"Wu, S. et al. Interobserver consistency and diagnostic challenges in HER2-ultralow breast cancer: a multicenter study. ESMO Open. 10 (2), 104127 (2025).","journal-title":"ESMO Open."},{"key":"42898_CR24","doi-asserted-by":"crossref","unstructured":"Lasseter, H. C. et al. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson\u2019s disease Vol. 2, p. 100027 (X, 2020). 2.","DOI":"10.1016\/j.cytox.2020.100027"},{"key":"42898_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2016.08.003","volume":"437","author":"D Yeung","year":"2016","unstructured":"Yeung, D. et al. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg\/mL levels of cytokines in human serum. J. Immunol. Methods. 437, 53\u201363 (2016).","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"42898_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/j.1365-2559.2011.04034.x","volume":"59","author":"AS Schrohl","year":"2011","unstructured":"Schrohl, A. S. et al. Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies. Histopathology 59 (5), 975\u2013983 (2011).","journal-title":"Histopathology"},{"issue":"2","key":"42898_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bbrc.2017.01.086","volume":"484","author":"L Qi","year":"2017","unstructured":"Qi, L. et al. Development of a highly specific HER2 monoclonal antibody for immunohistochemistry using protein microarray chips. Biochem. Biophys. Res. Commun. 484 (2), 248\u2013254 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"31","key":"42898_CR28","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff, A. C. et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Update. J. Clin. Oncol. 31 (31), 3997\u20134013 (2013).","journal-title":"J. Clin. Oncol."},{"key":"42898_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1208\/s12248-017-0146-9","volume":"19","author":"KJ Cowan","year":"2017","unstructured":"Cowan, K. J. et al. Recommendations for selection and characterization of protein biomarker assay calibrator material. AAPS J. 19, 1550\u20131563 (2017).","journal-title":"AAPS J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42898-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:04:48Z","timestamp":1778425488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42898-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42898"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42898-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14573"}}